REFERENCES
1. Liu, R., et al., Association of Cardiovascular Manifestations
with In-hospital Outcomes in Patients with COVID-19: A Hospital Staff
Data. medRxiv, 2020.
2. Sahin, A.R., et al., 2019 novel coronavirus (COVID-19)
outbreak: a review of the current literature. EJMO, 2020.4 (1): p. 1-7.
3. Organization, W.H., Coronavirus disease 2019 (COVID-19):
situation report, 67. 2020.
4. Bikdeli, B., et al., COVID-19 and thrombotic or thromboembolic
disease: implications for prevention, antithrombotic therapy, and
follow-up. Journal of the American College of Cardiology, 2020.
5. Thachil, J., et al., ISTH interim guidance on recognition and
management of coagulopathy in COVID‐19. Journal of Thrombosis and
Haemostasis, 2020. 18 (5): p. 1023-1026.
6. Poissy, J., et al., Pulmonary Embolism in COVID-19 Patients:
Awareness of an Increased Prevalence. Circulation, 2020.
7. Oxley, T.J., et al., Large-Vessel Stroke as a Presenting
Feature of Covid-19 in the Young. New England Journal of Medicine,
2020: p. e60.
8. Li, Y., et al., Acute cerebrovascular disease following
COVID-19: a single center, retrospective, observational study. 2020.
9. Branchford, B.R. and S.L. Carpenter, The role of inflammation
in venous thromboembolism. Frontiers in pediatrics, 2018. 6 :
p. 142.